PATHSTONE FAMILY OFFICE, LLC – Vertex Pharmaceuticals Incorporated Transaction History
PATHSTONE FAMILY OFFICE, LLC portfolio value:
$4.13M
portfolio value
PATHSTONE FAMILY OFFICE, LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +32.39% | 3.49K shares | 1.1M | $289.54 | 14.28K |
| Q2 2022 | share | Increase | +172.03% | 6.82K shares | 2M | $281.79 | 10.78K |
| Q1 2022 | share | Decrease | -11.55% | -518 shares | 52K | $260.97 | 3.96K |
| Q4 2021 | share | Increase | +70.98% | 1.86K shares | 510K | $222.45 | 4.48K |
| Q3 2021 | share | Increase | +14.55% | 333 shares | 13K | $181.39 | 2.62K |
| Q2 2021 | share | Increase | +15.84% | 313 shares | 37K | $201.63 | 2.28K |
| Q1 2021 | share | Increase | +228.79% | 1.37K shares | 283K | $214.89 | 1.97K |
| Q4 2020 | share | Increase | +17.84% | 91 shares | 3K | $236.34 | 601 |
| Q3 2020 | share | 0.00% | 0 shares | -9K | $272.12 | 510 | |
| Q2 2020 | share | 0.00% | 0 shares | 26K | $290.31 | 510 | |
| Q1 2020 | share | Increase | +104.82% | 261 shares | 121.45K | $237.95 | 510 |
| Q4 2019 | share | 0.00% | 0 shares | -41.45K | $218.95 | 249 | |
| Q3 2019 | share | 0.00% | 0 shares | -4K | $169.42 | 249 | |
| Q2 2019 | share | 0.00% | 0 shares | 0 | $183.38 | 249 | |
| Q1 2019 | share | Increase | 0.00% | 249 shares | 46K | $183.95 | 249 |
| Q2 2017 | share | Decrease | -100.00% | -38 shares | -4K | $128.87 | 0 |
| Q1 2017 | share | Increase | 0.00% | 38 shares | 4K | $109.35 | 38 |
| Q4 2016 | share | Decrease | -100.00% | -30 shares | -3K | $73.67 | 0 |
| Q3 2016 | share | Decrease | -47.37% | -27 shares | -2K | $87.21 | 30 |
| Q2 2016 | share | 0.00% | 0 shares | 1K | $86.02 | 57 | |
| Q1 2016 | share | Increase | 0.00% | 57 shares | 4K | $79.49 | 57 |